Shanghai Pharma Pays USD136.3 Million to Take Control of TCM Maker SHPL

Published on January 2, 2025

to sell a 45 percent stake to Shanghai Pharma and firms designated by Jinpu Healthcare Fund in a deal worth CNY9.95 billion (USD1.3 billion)

Continue reading on website
Other news

What investors should consider when starting a new SIP

January 2, 2025
or hybrid fund, as reported by ET Bureau.2 / 6 Correct Investment ApproachInvestors should build their long-term mutual fund portfolio

El papel del isomorfismo institucional para explicar la adopción voluntaria de las NIIF

January 2, 2025
Stock ownership and corporate performance in Japan: Corporate governance by institutional investors . RIETI Discussion Paper Series 10-E-005